There could soon be a new vaccine available – and it works in a completely different way than the others currently being used.
The US pharmaceutical company Novavax has put forward its Covid jab, Nuvaxovid for approval by Swissmedic.
The new drug will be the first protein vaccine available in the country. It contains a coronavirus spike protein which triggers the immune system.
In trials in the US and the UK, results suggest it provides a protection level of around 90%.
It does have another major advantage. It can be kept in a fridge for six months which makes distribution much easier.
Now medics against 10 million vote
Specific tax for foreigners could be discussed in Bern
Geneva bars open longer for World Cup
Meghan Markle appears in Geneva.
Woman landed with massive debt after fare evasion
Geneva night lights hit wildlife
